Is Hair Loss a Side Effect of Ozempic? Understanding the Connection

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Hair loss reports have emerged among individuals taking semaglutide and other GLP-1 receptor agonists, raising questions about whether the medications themselves trigger shedding or if weight loss drives the effect. Clinical data suggests the relationship is more nuanced than a direct drug side effect, and understanding your personal risk depends on multiple biological factors that PlexusDx can help identify.

How GLP-1 Medications Affect Hair Growth Cycles

Hair naturally cycles through growth, transition, and rest phases over months to years. When the body experiences rapid change—whether from calorie restriction, nutritional shifts, or metabolic stress—hair follicles can prematurely enter the telogen (resting) phase, causing increased shedding 2–3 months after the trigger. This process, called telogen effluvium, is temporary and reversible once the stressor resolves.

Semaglutide and tirzepatide work on appetite centers in the brain, not directly on hair follicles or scalp biology. The medications themselves do not bind to receptors in hair tissue. However, rapid weight loss—the intended therapeutic outcome—reduces caloric intake and can create nutritional gaps that stress hair follicle function, particularly in patients losing more than 1–2 pounds per week.

Clinical Evidence on Semaglutide and Hair Shedding

Pivotal trials for semaglutide (SUSTAIN series) and tirzepatide (SURMOUNT series) did not list alopecia or hair loss as primary or frequent adverse events. Incidence rates in trials were low and comparable to placebo groups, suggesting the drugs themselves carry minimal direct risk. However, real-world reports and social media discussions indicate some patients experience noticeable shedding during the first 6 months of treatment.

The discrepancy between trial data and patient reports highlights an important truth: telogen effluvium from weight loss can occur in any rapid-loss scenario—bariatric surgery, very-low-calorie diets, or illness recovery—and is not unique to GLP-1 therapy. Nutritional status, baseline hair health, genetics, and rate of weight loss all influence whether an individual experiences visible shedding. Studies specifically isolating GLP-1 as the causative factor remain limited.

Nutritional Factors That Influence Hair Health During Weight Loss

Hair follicles depend on adequate protein, iron, zinc, biotin, and B vitamins to maintain their growth phase. Rapid weight loss can reduce intake of these micronutrients, especially in patients who restrict food variety or fail to replace lost calories with nutrient-dense choices. Individuals already borderline deficient in these nutrients before starting semaglutide face higher risk of visible shedding.

PlexusDx recommends patients on GLP-1 therapy maintain adequate protein intake (0.8–1.0 grams per kilogram of ideal body weight daily), monitor iron and zinc levels quarterly, and consider targeted supplementation if deficiencies emerge. Hair health is a functional marker of overall nutritional status—addressing gaps through diet or supplementation often resolves telogen effluvium within 3–4 months.

Genetic Predisposition and Individual Hair Loss Risk

Your genetic makeup influences how your hair follicles respond to metabolic stress, weight loss rate, and nutritional changes. The FTO gene (rs9939609) and MC4R gene (rs17782313) variants associated with weight regulation also affect metabolic rate and nutrient partitioning during calorie reduction. Individuals carrying certain alleles may experience more pronounced shedding during rapid weight loss, while others shed minimally despite significant fat loss.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is hair loss a direct side effect of semaglutide or tirzepatide?

No. Hair loss in GLP-1 therapy is typically telogen effluvium triggered by rapid weight loss and nutritional stress, not by the medications themselves. Clinical trials did not identify alopecia as a frequent adverse event, and the medications do not directly target hair follicle biology. However, the significant appetite suppression and rapid weight loss these drugs enable can indirectly stress hair health if nutritional intake is inadequate.

How long does GLP-1-related hair shedding typically last?

If hair loss occurs, it usually begins 2–3 months after starting treatment and resolves within 3–6 months of addressing the underlying cause. Telogen effluvium is reversible; most people regain their baseline hair density once weight loss stabilizes and nutritional status improves. Ensuring adequate protein, iron, zinc, and B vitamins accelerates recovery.

Can I prevent hair loss while taking semaglutide?

Yes. Maintain consistent protein intake, slow your weight loss pace to 1–2 pounds per week when possible, monitor micronutrient levels, and supplement iron, zinc, and biotin if deficient. PlexusDx providers can review your nutritional strategy and genetics to personalize risk reduction. The Precision Peptide Genetic Test identifies your individual metabolic risk profile, helping your clinician adjust your treatment and supplementation plan.

What does the Precision Peptide Genetic Test reveal about hair loss risk?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How does PlexusDx semaglutide pricing support long-term treatment success?

PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across all three commitment tiers—your dose may need to go up, but your price won't. No insurance is required, and the medication is HSA/FSA eligible. This transparent pricing from licensed 503A compounding pharmacies means you can focus on consistent, sustainable weight loss without financial barriers interrupting your treatment.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Glp 1 Hair Loss Plexusdx
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.